Elevation Oncology Stock Predictions

Healthcare > Biotechnology

Buy ELEV

*Your capital is at risk

$0.365

+0 (+0%)

At Close: Oct 22, 2025

Currently predicting for Thu, 6 Aug 2026

ELEV Live board

Community Bull/Bear

Target Next close

Join the ELEV prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

ELEV Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For ELEV

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

ELEV Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT ELEVATION ONCOLOGY, INC.

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is bas...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
N NXDR $2.27	7.93%	Aug 03
MC $67.08	3.53%	Jul 31
FCX $62.63	10.79%	Jul 31
ARW $212.85	6.58%	Jul 30
BIIB $202.19	2.20%	Jul 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by